Carregant...
Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
Background: In clinical practice, common problem polypharmacy could result in the increased risks of drug–drug interactions (DDIs). Co-administered imatinib (IMA) and voriconazole (VOR) as one treatment protocol in cancer patients with fungal infections are common.Purpose: The aim of the present stu...
Guardat en:
| Publicat a: | Infect Drug Resist |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502443/ https://ncbi.nlm.nih.gov/pubmed/31118708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S199526 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|